Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOCICLIB vs RIFAPENTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBOCICLIB vs RIFAPENTINE: Safety Overview

Metric RIBOCICLIB RIFAPENTINE
Total FAERS Reports 27,997 298
Deaths Reported 4,501 8
Death Rate 16.1% 2.7%
Hospitalizations 6,700 88
Average Patient Age 60.2 yrs 46.5 yrs
% Female Patients 99.0% 55.6%
FDA Approval Date Mar 13, 2017 Jun 22, 1998
Manufacturer Novartis Pharmaceuticals Corporation sanofi-aventis U.S. LLC
Route ORAL ORAL
Marketing Status Prescription Prescription